You are here

  • Home
  • Archive
  • Volume 15, Issue 6
  • Low-dose and high-dose colchicine have comparable efficacy in the treatment of acute gout, but high dose carries significantly greater risk of adverse effects

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Low-dose and high-dose colchicine have comparable efficacy in the treatment of acute gout, but high dose carries significantly greater risk of adverse effects

https://doi.org/10.1136/ebm1119

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests BFM had consulted once for URL, the sponsor of this study. However, he did not have any role in the study design or conduct.